Doo Sun Sim

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

Medicine, Endocrinology, Pharmacology +14

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text

Medicine, Endocrinology, Nephrology +15

Value of Early Risk Stratification Using Hemoglobin Level and Neutrophil-to-Lymphocyte Ratio in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

Kyung Hoon Cho, Myung Ho Jeong, Daisuke Hachinohe et al. · The American Journal of Cardiology · 2011 · 102 citations

Medicine, Cardiology, Hematology +12

Feasibility of Coronary Angiography and Percutaneous Coronary Intervention via Left Snuffbox Approach

Yongcheol Kim, Youngkeun Ahn, Inna Kim et al. · Korean Circulation Journal · 2018 · 90 citations · Full text

Medicine, Cardiology, Surgery +17

Early Left Ventricular Unloading or Conventional Approach After Venoarterial Extracorporeal Membrane Oxygenation: The EARLY-UNLOAD Randomized Clinical Trial

Min Chul Kim, Yongwhan Lim, Seung Hun Lee et al. · Circulation · 2023 · 86 citations

Medicine, Cardiology, Cardiothoracic Surgery +12